Vancouver, British Columbia –TheNewswire -November 29, 2021 – Blackhawk Growth Corp. (CSE:BLR);(CSE:BLR); (OTC:BLRZF);(Frankfurt:0JJ) (the "Company"),is pleased to announce that the financial statements and MD&A for its first quarter ended September 30, 2021 have been filed on Sedar.

Highlights for the quarter ended September 30, 2021:

• Blackhawk acquires MindBio Therapeutics Pyt Ltd.,clinical stage drug development company that is pioneering psychedelic micro-dosing research and is advancing emerging therapies to treat a range of debilitating health conditions such as depression, anxiety, chronic pain, cognitive impairment and PTSD.

• Spaced Food Inc. begins commercial production of it proprietary Astronaut Sorbet

• Sac Pharma Partners...